An analysis of 1,129 deals, $26.3 billion in capital, and the market dynamics that headlines miss.
When xAI raised $20 billion in a single round and OpenAI hit a $500 billion valuation, the message seemed clear: AI funding is a game of superlatives. Go big or go home.
But buried beneath the mega-round headlines is a different story. One told by 1,129 Series A deals totaling $26.32 billion in 2025.
The median deal? Just $16 million.
That’s not a typo. In a year where foundation models absorbed $80 billion and 58% of AI funding flowed to $500M+ mega-rounds, the typical Series A AI company raised a disciplined round that would barely cover two months of compute costs for a frontier lab.
This report goes beyond the numbers we published in our newsletter. We analyzed all 1,129 deals across 264 cities, 15 sectors, and 20+ technology categories to understand what Series A AI funding actually looks like — who’s investing, where the money goes, and what the data says about where the market is heading.

On this page
- The Mega-Round Mirage
- Where the Money Actually Goes: Deal Size Distribution
- The Quiet Majority: 84% of Deals Happen Outside San Francisco
- The Second City Premium: Boston vs. London
- Sector Deep Dive: Where AI Capital Deploys
- Technology Trends: The AI Agents Supercycle
- The AI Stack: Applications vs. Infrastructure
- Quarterly Seasonality: When Money Moves
- The Investor Landscape: Who's Writing Checks
- Five Shifts for Investors and Founders
- Key Takeaways
- Methodology
The Mega-Round Mirage
Media coverage of AI funding has created a distorted picture of what raising Series A actually looks like. When every headline features nine-figure rounds, founders internalize a false benchmark.
The distortion by numbers:
- Foundation models captured $80B in 2025 (40% of all AI funding)
- 58% of total AI funding went to $500M+ mega-rounds
- Top 3 deals (xAI, OpenAI, Anthropic) absorbed roughly $50B alone
- Yet the median Series A was $16M — 1,250x smaller than xAI’s raise
The consequence? Founders either chase unrealistic valuations, feel inadequate raising “only” $15-25M, or over-concentrate on San Francisco assuming geography determines fundability.
Series A remains the last stage where traditional venture economics apply. Price discovery works. Fundamentals matter. And 1,129 companies proved it.
Where the Money Actually Goes: Deal Size Distribution
The $16M median masks an informative distribution. Two-thirds of all Series A AI deals fell into a single band — and it tells us exactly what “normal” looks like at this stage.

| Deal Size | Deals | Funding | Share of Capital |
|---|---|---|---|
| < $1M | 4 | $2.7M | 0.0% |
| $1M – $5M | 61 | $188M | 0.7% |
| $5M – $10M | 159 | $1.14B | 4.3% |
| $10M – $50M | 755 | $15.1B | 57.6% |
| $50M – $100M | 68 | $4.2B | 16.0% |
| > $100M | 36 | $5.6B | 21.4% |
The $10-50M band is where Series A lives. It accounts for 66.9% of all deals and 57.6% of capital deployed. The 36 deals above $100M attracted outsized attention but represented just 3.2% of deal count.
This creates two distinct economies within a single funding stage. The disciplined majority — companies raising $10-50M with realistic 18-24 month runways at $700K-900K monthly burn. And the outlier class — 36 companies averaging $156M per round, facing impossible math where they need $500M+ Series B rounds to avoid down rounds.
As Anders Ranum, Partner at Sapphire Ventures, declared: “2026 is a fundamentals-first year where capital rewards revenue growth, efficiency and real AI advantage, and punishes anything that is AI veneer on old ideas.”
The $16M median isn’t a ceiling. It’s a sanity check.
The Quiet Majority: 84% of Deals Happen Outside San Francisco
951 deals happened outside San Francisco. That’s 84.2% of Series A activity — the quiet majority that headlines ignore.

| Metro | Deals | Total Funding | Avg Deal Size |
|---|---|---|---|
| San Francisco | 178 | $4.15B | $23.3M |
| New York City | 132 | $2.88B | $21.8M |
| London | 58 | $1.23B | $21.2M |
| Boston | 38 | $1.15B | $30.3M |
| Tel Aviv | 26 | $672M | $25.8M |
| Los Angeles | 23 | $274M | $11.9M |
| Paris | 22 | $610M | $27.7M |
| Seattle | 18 | $357M | $19.8M |
| Singapore | 18 | $325M | $18.0M |
| Austin | 16 | $632M | $39.5M |

The paradox: 65%+ of AI-focused VC capital is managed by SF-based firms, yet 84% of deals happen elsewhere. This creates a structural inefficiency — SF VCs must compete intensely locally or travel extensively for non-local deals.
The Second City Premium: Boston vs. London

Boston: Conviction Capital
- 38 deals, $1.15B total
- $30.3M average — highest of major metros, 30% higher than SF
Boston’s biotech-AI convergence attracts drug discovery, computational biology, and clinical AI — categories requiring larger rounds due to regulatory timelines and data requirements. MIT/Harvard spinouts have established credibility. Flagship, Atlas, and Third Rock write larger checks for longer holds.
Notable deals: Layer Health ($21M, clinical decision support), 7AI ($130M, cybersecurity), OpenHands ($18.8M, AI coding agents).
London: Experimentation at Scale
- 58 deals, $1.23B total
- $21.2M average with 53% more deals than Boston
US companies often establish London offices for European expansion, captured in UK deal flow. SEIS/EIS tax advantages make early-stage funding more accessible. The DeepMind legacy plus Imperial/UCL/Cambridge create continuous startup formation.
Notable deals: Ultralytics ($30M, YOLO computer vision), nsave ($18M, fintech infrastructure), Fyxer AI ($10M, 20VC-backed).
Both work. Similar total funding ($1.15B vs. $1.23B) suggests neither approach is strictly superior. Founders should match their strategy to market.
Sector Deep Dive: Where AI Capital Deploys
Series A AI funding isn’t a monolith. It’s 15 distinct markets, each with different dynamics, deal sizes, and investor profiles.

Health & Biotech leads in capital deployed ($7.71B across 230 deals) with an average deal of $33.5M — the highest of any major sector. Drug discovery and precision medicine rounds run larger because regulatory timelines demand longer runways.
Enterprise Software leads in deal count (279 deals, $5.79B) with a more modest $20.7M average. This is the broadest category, spanning AI agents, document automation, and data management.
FinTech holds the middle ground (192 deals, $4.02B) at $20.9M average. Compliance automation and risk assessment drive deal flow.

The Funding Efficiency Gap
Five sectors are systematically underfunded relative to the market average of $24.3M:
| Sector | Avg Deal | vs. Market Avg | Severity |
|---|---|---|---|
| Education Technology | $14.1M | 58% of average | Moderate |
| Retail & E-Commerce | $14.1M | 58% of average | Moderate |
| Food & AgriTech | $14.9M | 61% of average | Moderate |
| Real Estate & Construction | $15.8M | 65% of average | Moderate |
| Marketing & Sales Tech | $17.0M | 70% of average | Moderate |
These underfunded sectors represent opportunity for investors willing to go against consensus. The gap between market size and funding intensity signals either a timing mismatch or structural bias in VC allocation.
Technology Trends: The AI Agents Supercycle

AI Agents commanded 257 deals and $6.07B — more deals than any other technology category by a wide margin. This reflects the industry’s pivot from “AI that generates” to “AI that acts.”
But the most capital-efficient tag tells a different story. Biotechnology attracted just 91 deals but commanded $4.53B — an average of $49.8M per deal, more than double the market average. Drug Discovery (64 deals, $4.05B) and Therapeutics (67 deals, $3.92B) follow the same pattern: fewer deals, larger checks, longer conviction horizons.
| Tag | Deals | Total Funding | Avg per Deal |
|---|---|---|---|
| Drug Discovery | 64 | $4.05B | $63.2M |
| Biotechnology | 91 | $4.53B | $49.8M |
| Therapeutics | 67 | $3.92B | $58.5M |
| Precision Medicine | 62 | $2.58B | $41.7M |
| Robotics | 60 | $2.44B | $40.7M |
| Industrial Automation | 111 | $3.04B | $27.4M |
| Payments | 64 | $1.71B | $26.7M |
| AI Agents | 257 | $6.07B | $23.6M |
| Threat Detection | 64 | $1.40B | $21.9M |
| Supply Chain | 100 | $2.01B | $20.1M |
The AI Stack: Applications vs. Infrastructure

AI Applications: 914 deals (79.2%), $20.8B total. AI Native: 580 deals, $13.6B (companies that couldn’t exist without AI). AI Augmented: 334 deals, $7.2B (existing products enhanced with AI).
AI Infrastructure: 167 deals (20.8%), $5.5B total. AI Adjacent: 104 deals, $2.8B (enabling AI but not running models). AI Platforms: 63 deals, $2.6B (building foundation models/chips).
The infrastructure layer captures disproportionate funding per deal. AI Platforms average $41.9M per deal versus AI Native’s $23.4M. Infrastructure rounds run larger because the capital requirements — compute, data pipelines, specialized hardware — demand it.
Vertical vs. Horizontal: Vertical AI (industry-specific) captured 880 deals (81.4%), while Horizontal AI (cross-industry) had 203 deals (18.6%). The overwhelming preference for vertical AI at Series A makes sense — investors at this stage want clear markets, identifiable customers, and measurable revenue.
Quarterly Seasonality: When Money Moves

| Quarter | Deals | Funding | Median Deal | QoQ Change |
|---|---|---|---|---|
| Q1 2025 | 286 | $6.96B | $15.2M | — |
| Q2 2025 | 271 | $5.82B | $15.0M | -16.4% |
| Q3 2025 | 273 | $7.15B | $16.0M | +23.0% |
| Q4 2025 | 253 | $6.38B | $17.0M | -10.8% |
Two patterns stand out. First, deal count was remarkably stable — between 253 and 286 deals per quarter, never varying more than 13%. Second, median deal size crept upward from $15.2M in Q1 to $17.0M in Q4 — a 12% increase suggesting gradual pricing inflation.
For founders, the implication is tactical: avoid raising in August, target September-November or January-March for optimal market conditions.
The Investor Landscape: Who’s Writing Checks

Y Combinator dominates with 67 deals ($1.41B in deal value), functioning as the de facto pipeline for Series A AI companies. Six of the top 13 co-investment pairs involve YC as one partner.
The tier below YC shows a five-way tie at 20-21 deals: Andreessen Horowitz (21 deals, $650M), General Catalyst (20 deals, $1.03B), Lightspeed (20 deals, $921M), Accel (20 deals, $635M), and Insight Partners (20 deals, $451M).

Five Shifts for Investors and Founders
1. The Median Is the Message
Stop using mega-rounds as benchmarks. A $16M Series A with 3x growth to Series B is a success. Companies raising $16M face realistic expectations: 18-24 month runway, clear metrics for progression. Companies raising $100M+ face impossible math.
2. Geographic Arbitrage Is Real
951 deals outside SF represent structural deal flow opportunity. An SF AI engineer costs $350-500K fully loaded. Boston: $250-350K. London: $180-280K. The same $16M buys 40-60% more runway outside the Valley.
3. Vertical AI Is the Series A Sweet Spot
81.4% of deals targeted specific industries. At the $16M level, vertical focus — identifiable customers, measurable revenue, clear competitive moats — is what investors fund.
4. The Underfunded Sectors Are Your Opportunity
Education Technology, Retail/E-Commerce, Food/AgriTech, and Real Estate all raise 35-42% below market average. These sectors have massive TAMs but lack dedicated AI capital. For investors, this is where contrarian bets live.
5. The Series B Bottleneck Is Coming
1,129 Series A companies will compete for Series B in 2026-2027. Series B capacity hasn’t scaled proportionally. The discipline advantage compounds — companies that raised $16M with realistic expectations have options when Series B tightens.
Key Takeaways
For Founders
- The typical Series A AI round is $16M, not $100M. Build your plan accordingly.
- 84% of deals close outside San Francisco. Location matters less than execution and customer proximity.
- Target September-November or January-March for optimal fundraising conditions. Avoid August.
- Vertical AI (81% of deals) is what Series A investors fund. Prove your market before going horizontal.
For Investors
- Y Combinator’s 67-deal pipeline makes it the essential Series A feeder. Build or maintain YC relationships.
- Five sectors (EdTech, Retail, AgriTech, Real Estate, MarTech) are systematically underfunded at 58-70% of market average.
- Boston ($30.3M avg) and Austin ($39.5M avg) produce the largest deals. London (58 deals) produces the most volume outside the US.
- The AI Applications layer (79% of deals) is where volume lives, but AI Infrastructure (21%) captures higher per-deal economics.
For the Market
- Series A is the last rational stage in AI — pricing discipline still holds at $16M median.
- 264 cities participated in AI Series A funding in 2025. The geographic distribution is far wider than narrative suggests.
- Biotech/drug discovery commands 2-3x the per-deal funding of software categories. Two parallel markets exist within Series A.
- Q4 2025’s rising median ($17M) signals gradual pricing inflation heading into 2026.
Methodology
Analysis Period: January 1 — December 31, 2025
Data Source: Bot Memo proprietary database. 1,129 Series A AI funding rounds with disclosed amounts.
Inclusion Criteria: Announced funding amount from disclosed rounds. Company self-identifies as AI/ML-focused or uses AI in core product. Series A designation confirmed by company or lead investor.
Exclusion Criteria: Undisclosed amounts not estimated. Debt financing, grants, and ICOs excluded. Secondary transactions excluded. Series A extensions counted with original round unless separately announced.
Key Metrics: Median calculated across all 1,129 disclosed deals. Averages calculated as total funding divided by deal count per geography. Metro assignment based on company HQ at time of announcement.
Limitations: Undisclosed rounds not included — may skew toward larger disclosed deals. Multi-HQ companies assigned to primary location. Currency converted to USD at announcement-date exchange rates.
This analysis is based on Bot Memo’s proprietary database of 1,129 Series A AI funding rounds in 2025. Bot Memo catalogs AI startups worldwide to surface investable market gaps for VCs and founders. Subscribe to our newsletter for weekly analysis.


